SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-056036
Filing Date
2019-11-12
Accepted
2019-11-12 16:37:31
Documents
1
Period of Report
2019-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 16249
  Complete submission text file 0001209191-19-056036.txt   17704
Mailing Address 240 LEIGH FARM ROAD DURHAM NC 27707
Business Address 240 LEIGH FARM ROAD DURHAM NC 27707 919-806-4487
Dova Pharmaceuticals Inc. (Issuer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DOVA PHARMACEUTICALS, INC. 240 LEIGH FARM ROAD, SUITE 245 DURHAM NC 27707
Business Address
Laliberte Kevin (Reporting) CIK: 0001709417 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38135 | Film No.: 191210161